Thane Wettig, Chief Commercial Officer at FIBROGEN INC (FGEN), sold 27,868 shares at $21.16 ($575K) on 2023-03-08, disclosed to the SEC on 2023-03-10.
Open-market sale of $575k FGEN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.16 | 6,265 | $133K | 23.1% |
| 2 | $21.16 | 6,265 | $133K | 23.1% |
| 3 | $20.20 | 2,938 | $59K | 10.3% |
| 4 | $20.20 | 2,938 | $59K | 10.3% |
| 5 | $20.20 | 4,731 | $96K | 16.6% |
| 6 | $20.20 | 4,731 |
| $96K |
| 16.6% |
| Total | $20.63 avg | 27,868 | $575K | 100% |
| Filing → |
| FGEN | BUY | 2025-03-25 | $51K | — | Filing → |
| FGEN | BUY | 2024-03-11 | $96K | — | Filing → |
| FGEN | SELL | 2023-06-26 | $13K | — | Filing → |